🟢 Kailera Therapeutics is trading 4.01% up in pre-market amid firmer Nasdaq futures, no fresh company catalyst

Kailera Therapeutics is trading at $18.16, up 4.01% in pre-market on August 21, 2026, primarily amid stronger broader risk sentiment.

• Nasdaq Composite futures are up 0.61%.
• No fresh company-specific announcement was identified overnight; recent coverage remains focused on the August 12 second-quarter report, which showed a $111.3 million net loss and cash runway into mid-2028.
• The move appears tied to broader risk sentiment rather than a new corporate catalyst.